NYSE:NVRO (USA) Also trade in: Germany

Nevro Corp

$ 59.32 -1.17 (-1.93%)
Volume: 351,714 Avg Vol (1m): 713,787
Market Cap $: 1.81 Bil Enterprise Value $: 1.73 Bil
P/E (TTM): 0.00 P/B: 8.41
Earnings Power Value -20.28
Net Current Asset Value 5.46
Tangible Book 7.05
Projected FCF 0
Median P/S Value 107.67
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 1.55
Cash-To-Debt ranked lower than
53.33% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
NVRO: 1.55
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 1.55, Med: 2.13, Max: 10000
Current: 1.55
1.55
10000
Equity-to-Asset 0.47
Equity-to-Asset ranked lower than
64.08% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
NVRO: 0.47
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.47, Med: 0.59, Max: 0.89
Current: 0.47
0.47
0.89
Debt-to-Equity 0.72
Debt-to-Equity ranked lower than
72.27% of 220 companies
in the Medical Devices industry.
Industry Max: 11.69, Med: 0.3, Min: 0.01
NVRO: 0.72
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0.08, Med: 0.57, Max: 0.72
Current: 0.72
0.08
0.72
Debt-to-EBITDA -2.60
Debt-to-EBITDA ranked lower than
100.00% of 158 companies
in the Medical Devices industry.
Industry Max: 3384.46, Med: 1.98, Min: 0.02
NVRO: -2.6
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -6.35, Med: -4.46, Max: -0.31
Current: -2.6
-6.35
-0.31
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.87
DISTRESS
GREY
SAFE
Beneish M-Score -0.30
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -52.33%
WACC 8.76%

Profitability & Growth : 2/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -17.89
Operating Margin ranked lower than
62.18% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
NVRO: -17.89
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -107.03, Med: -86.9, Max: -9.05
Current: -17.89
-107.03
-9.05
Net Margin % -19.79
Net Margin ranked lower than
62.82% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
NVRO: -19.79
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -110.7, Med: -94.19, Max: -11.22
Current: -19.79
-110.7
-11.22
ROE % -31.70
ROE ranked lower than
63.82% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
NVRO: -31.7
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -47.12, Med: -25.74, Max: -13.14
Current: -31.7
-47.12
-13.14
ROA % -16.67
ROA ranked lower than
59.94% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
NVRO: -16.67
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -41.78, Med: -22.08, Max: -8.29
Current: -16.67
-41.78
-8.29
ROC (Joel Greenblatt) % -50.48
ROC (Joel Greenblatt) ranked lower than
61.16% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
NVRO: -50.48
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -244.06, Med: -146.42, Max: -21.89
Current: -50.48
-244.06
-21.89
3-Year Total Revenue Growth Rate 77.20
3-Year Revenue Growth Rate ranked higher than
75.98% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
NVRO: 70.1
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -53.9, Med: -9.15, Max: 70.1
Current: 70.1
-53.9
70.1
3-Year Total EBITDA Growth Rate 18.40
3-Year EBITDA Growth Rate ranked higher than
90.52% of 232 companies
in the Medical Devices industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
NVRO: 21.7
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 21.7, Med: 53.8, Max: 70.2
Current: 21.7
21.7
70.2
3-Year EPS w/o NRI Growth Rate 13.60
3-Year EPS w/o NRI Growth Rate ranked higher than
87.00% of 223 companies
in the Medical Devices industry.
Industry Max: 241, Med: 7.8, Min: -413
NVRO: 13.6
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 28.55, Max: 66.5
Current: 13.6
0
66.5

» NVRO's 30-Y Financials

Financials (Next Earnings Date: 2019-07-16)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:NVRO

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 334510    SIC : 3845
Compare XSWX:MOVE NAS:INGN TSE:3360 TSE:8086 SZSE:300633 XSWX:YPSN NAS:CNMD OCSE:OSSR NYSE:ITGR HKSE:00853 TSE:7817 TSE:6849 TSE:7575 NAS:CSII SZSE:002317 NAS:SILK XSWX:TECN NYSE:INSP NAS:SWAV SZSE:300326
Traded in other countries 1N7.Germany
Address 1800 Bridge Parkway, Redwood City, CA, USA, 94065
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.

Ratios

Current vs industry vs history
PB Ratio 8.41
PB Ratio ranked lower than
87.42% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
NVRO: 8.41
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 4.36, Med: 8.36, Max: 12.06
Current: 8.41
4.36
12.06
PS Ratio 4.67
PS Ratio ranked lower than
74.49% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
NVRO: 4.67
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 1.5, Med: 8.51, Max: 35.2
Current: 4.67
1.5
35.2
EV-to-EBIT -26.86
EV-to-EBIT ranked lower than
100.00% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
NVRO: -26.86
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -114.2, Med: -45.1, Max: -14.6
Current: -26.86
-114.2
-14.6
EV-to-EBITDA -29.12
EV-to-EBITDA ranked lower than
100.00% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
NVRO: -29.12
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -123.1, Med: -47, Max: -14.7
Current: -29.12
-123.1
-14.7
EV-to-Revenue 4.49
EV-to-Revenue ranked lower than
71.52% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
NVRO: 4.49
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 2.6, Med: 10, Max: 33.6
Current: 4.49
2.6
33.6
Current Ratio 6.30
Current Ratio ranked higher than
89.81% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
NVRO: 6.3
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 6.15, Med: 9.38, Max: 18.63
Current: 6.3
6.15
18.63
Quick Ratio 4.87
Quick Ratio ranked higher than
87.96% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
NVRO: 4.87
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 4.76, Med: 7.65, Max: 17.25
Current: 4.87
4.76
17.25
Days Inventory 293.36
Days Inventory ranked lower than
85.37% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
NVRO: 293.36
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 293.36, Med: 379.76, Max: 501.59
Current: 293.36
293.36
501.59
Days Sales Outstanding 66.01
Days Sales Outstanding ranked lower than
57.25% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
NVRO: 66.01
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 66.01, Med: 84.37, Max: 118.1
Current: 66.01
66.01
118.1
Days Payable 71.82
Days Payable ranked higher than
55.94% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
NVRO: 71.82
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 68.19, Med: 94.56, Max: 284.1
Current: 71.82
68.19
284.1

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -2.20
3-Year Share Buyback Rate ranked lower than
52.46% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
NVRO: -2.2
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -245.9, Med: -113.35, Max: -2.2
Current: -2.2
-245.9
-2.2

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 8.41
Price-to-Tangible-Book ranked lower than
76.45% of 276 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 4.5, Min: 0.07
NVRO: 8.41
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 4.79, Med: 8.34, Max: 12.06
Current: 8.41
4.79
12.06
Price-to-Median-PS-Value 0.55
Price-to-Median-PS-Value ranked higher than
74.68% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
NVRO: 0.55
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.21, Med: 0.97, Max: 3.96
Current: 0.55
0.21
3.96
Earnings Yield (Joel Greenblatt) % -3.73
Earnings Yield (Greenblatt) ranked lower than
57.23% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
NVRO: -3.73
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -6.8, Med: -2.2, Max: -0.9
Current: -3.73
-6.8
-0.9

More Statistics

Revenue (TTM) (Mil) $ 381.8
EPS (TTM) $ -2.49
Beta 1.08
Volatility % 66.18
52-Week Range $ 34.75 - 86.75
Shares Outstanding (Mil) 30.52

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 2
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y